Inhibikase Therapeutics, Inc. — DEF 14A Filings
7 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Inhibikase Therapeutics, Inc. (IKT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Inhibikase Therapeutics, Inc. has filed 7 DEF 14A documents with the SEC since 2018. To view all SEC filings by Inhibikase Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0000950170-25-069152 | May 12, 2025 | Jun 27, 2025 |
| DEF 14A | DEF 14A | 0000950170-24-127941 | Nov 18, 2024 | Jan 3, 2025 |
| DEF 14A | DEF 14A | 0000950170-24-075675 | Jun 20, 2024 | Aug 5, 2024 |
| DEF 14A | DEF 14A | 0000950170-24-049145 | Apr 26, 2024 | Jun 7, 2024 |
| DEF 14A | DEF 14A | 0000950170-23-018354 | May 5, 2023 | Jun 23, 2023 |
| DEF 14A | DEF 14A | 0000950170-22-006898 | May 2, 2022 | Jun 24, 2022 |
| DEF 14A | DEF 14A | 0001193125-21-145678 | Apr 30, 2021 | Jun 25, 2021 |